Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors.
暂无分享,去创建一个
J. Ballesteros | J. Javitch | Lei Shi | J A Javitch | J A Ballesteros | L Shi | L. Shi | L. Shi
[1] P. Kitabgi,et al. Mutagenesis and Modeling of the Neurotensin Receptor NTR1 , 1998, The Journal of Biological Chemistry.
[2] H. Khorana,et al. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. , 1995, Biochemistry.
[3] D. Oprian,et al. The ligand-binding domain of rhodopsin and other G protein-linked receptors , 1992, Journal of bioenergetics and biomembranes.
[4] H. Akil,et al. Hydrophobic Residues of the D2 Dopamine Receptor Are Important for Binding and Signal Transduction , 1995, Journal of neurochemistry.
[5] T. Schwartz,et al. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor , 1995, Nature.
[6] D. Oprian,et al. Tertiary interactions between transmembrane segments 3 and 5 near the cytoplasmic side of rhodopsin. , 1999, Biochemistry.
[7] F Guarnieri,et al. Agonist-induced Conformational Changes at the Cytoplasmic Side of Transmembrane Segment 6 in the β2 Adrenergic Receptor Mapped by Site-selective Fluorescent Labeling* , 2001, The Journal of Biological Chemistry.
[8] O. Lichtarge,et al. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.
[9] T. Branchek,et al. Modeling and mutagenesis of the human alpha 1a-adrenoceptor: orientation and function of transmembrane helix V sidechains. , 1996, Receptors & channels.
[10] C Altenbach,et al. Structural features and light-dependent changes in the sequence 306-322 extending from helix VII to the palmitoylation sites in rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.
[11] Harel Weinstein,et al. Three-dimensional representations of G protein-coupled receptor structures and mechanisms. , 2002, Methods in enzymology.
[12] B. Honig,et al. An integrated approach to the analysis and modeling of protein sequences and structures. III. A comparative study of sequence conservation in protein structural families using multiple structural alignments. , 2000, Journal of molecular biology.
[13] A. Smolyar,et al. Static and dynamic roles of extracellular loops in G-protein-coupled receptors: a mechanism for sequential binding of thyrotropin-releasing hormone to its receptor. , 1998, Biophysical journal.
[14] M. Caron,et al. Localization of the fourth membrane spanning domain as a ligand binding site in the human platelet alpha 2-adrenergic receptor. , 1989, Biochemistry.
[15] S. Rivkees,et al. Identification of the Adenine Binding Site of the Human A1 Adenosine Receptor* , 1999, The Journal of Biological Chemistry.
[16] J. Thornton,et al. Helix geometry in proteins. , 1988, Journal of molecular biology.
[17] C. Strader,et al. Allele-specific activation of genetically engineered receptors. , 1991, The Journal of biological chemistry.
[18] H Weinstein,et al. Related Contribution of Specific Helix 2 and 7 Residues to Conformational Activation of the Serotonin 5-HT2A Receptor (*) , 1995, The Journal of Biological Chemistry.
[19] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[20] J. Ballesteros,et al. Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.
[21] M. Struthers,et al. G protein-coupled receptor activation: analysis of a highly constrained, "straitjacketed" rhodopsin. , 2000, Biochemistry.
[22] J. Baldwin,et al. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.
[23] R. Graham,et al. Phe310 in Transmembrane VI of the α1B-Adrenergic Receptor Is a Key Switch Residue Involved in Activation and Catecholamine Ring Aromatic Bonding* , 1999, The Journal of Biological Chemistry.
[24] A. Egloff,et al. Replacement of lysine‐181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling , 1992, Journal of cellular biochemistry.
[25] C. Fraser,et al. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. , 1991, Molecular pharmacology.
[26] B. Roth,et al. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5. , 2000, Molecular pharmacology.
[27] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[28] K. Jacobson,et al. Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. , 1992, The Journal of biological chemistry.
[29] J. Ballesteros,et al. Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment. , 1999, Biochemistry.
[30] O. Lichtarge,et al. Similar Structures and Shared Switch Mechanisms of the β2-Adrenoceptor and the Parathyroid Hormone Receptor , 1999, The Journal of Biological Chemistry.
[31] T. Schwartz,et al. Connectivity and orientation of the seven helical bundle in the tachykinin NK‐1 receptor probed by zinc site engineering. , 1996, The EMBO journal.
[32] Yi-Jun Guo,et al. Molecular basis for the interaction of histamine with the histamine H2 receptor. , 1992, The Journal of biological chemistry.
[33] Irving S. Sigal,et al. Structure-Function Analysis of the β-Adrenergic Receptor , 1988 .
[34] G. Liapakis,et al. Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors. , 2002, Methods in enzymology.
[35] G. Crouse. Mutagenesis assays in yeast. , 2000, Methods.
[36] D. Larhammar,et al. Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT(1B) receptor. , 1999, European journal of pharmacology.
[37] M. Struthers,et al. Tertiary interactions between the fifth and sixth transmembrane segments of rhodopsin. , 1999, Biochemistry.
[38] [8] Domain approach to three-dimensional structure of rhodopsin using high-resolution nuclear magnetic resonance , 2000 .
[39] Shoshana J. Wodak,et al. The TXP Motif in the Second Transmembrane Helix of CCR5 , 2001, The Journal of Biological Chemistry.
[40] L. Naylor,et al. Structural Studies on D2 Dopamine Receptors: Mutation of a Histidine Residue Specifically Affects the Binding of a Subgroup of Substituted Benzamide Drugs , 1994, Journal of neurochemistry.
[41] C. Broger,et al. Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors. , 1995, European journal of biochemistry.
[42] T. Mavromoustakos,et al. Amphipathic interactions of cannabinoids with membranes. A comparison between delta 8-THC and its O-methyl analog using differential scanning calorimetry, X-ray diffraction and solid state 2H-NMR. , 1992, Biochimica et biophysica acta.
[43] B. Kobilka,et al. Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors. , 1992, Molecular pharmacology.
[44] S. W. Lin,et al. Analysis of functional microdomains of rhodopsin. , 2000, Methods in enzymology.
[45] Manju Bansal,et al. Geometrical and Sequence Characteristics of α-Helices in Globular Proteins , 1998 .
[46] U. Gether. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.
[47] J. Ballesteros,et al. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. , 1998, Biochemistry.
[48] D. Perez,et al. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding. , 1996, Molecular pharmacology.
[49] B. Roth,et al. Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors. , 1997, Molecular pharmacology.
[50] S. Vishveshwara,et al. Geometry of proline-containing alpha-helices in proteins. , 2009, International journal of peptide and protein research.
[51] C. Strader,et al. Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation. , 2000, Molecular pharmacology.
[52] B. Roth,et al. A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors. , 1993, Molecular pharmacology.
[53] B. Matthews,et al. Intrahelical hydrogen bonding of serine, threonine and cysteine residues within alpha-helices and its relevance to membrane-bound proteins. , 1984, Journal of molecular biology.
[54] J. Wess,et al. Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition. , 1996, Molecular pharmacology.
[55] Gebhard F. X. Schertler,et al. Arrangement of rhodopsin transmembrane α-helices , 1997, Nature.
[56] J. Ballesteros,et al. Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice. , 1996, Biochemistry.
[57] T. Schwartz,et al. Is there a 'lock' for all agonist 'keys' in 7TM receptors? , 1996, Trends in pharmacological sciences.
[58] C. Strader,et al. Identification and sequence of a binding site peptide of the beta 2-adrenergic receptor. , 1988, Biochemistry.
[59] In vitro selected oligonucleotides as receptors in binding assays. , 2000, Methods.
[60] B. Roth,et al. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. , 1995, Molecular pharmacology.
[61] D. Larhammar,et al. Mutagenesis of the human 5-HT1B receptor: differences from the closely related 5-HT1A receptor and the role of residue F331 in signal transduction. , 1998, Journal of receptor and signal transduction research.
[62] I. Gantz,et al. Molecular Basis for the Interaction of [Nle4,d-Phe7]Melanocyte Stimulating Hormone with the Human Melanocortin-1 Receptor (Melanocyte α-MSH Receptor)* , 1997, The Journal of Biological Chemistry.
[63] H Weinstein,et al. Mapping the Binding Site Pocket of the Serotonin 5-Hydroxytryptamine2A Receptor , 1996, The Journal of Biological Chemistry.
[64] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2000, Science.
[65] O. Civelli,et al. Site-directed mutagenesis of the human dopamine D 2 receptor , 2003 .
[66] J. Venter,et al. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. , 1989, Molecular pharmacology.
[67] Catherine,et al. dentific ~ tion f Two Serine Residues Involved in Agonist Activation of the & Adrenergic Receptor ” , 2022 .
[68] T. Sakmar,et al. [9] Analysis of functional microdomains of rhodopsin , 2000 .
[69] Mark S.P. Sansom,et al. Hinges, swivels and switches: the role of prolines in signalling via transmembrane α-helices , 2000 .
[70] L. Pardo,et al. Serine and Threonine Residues Bend a-Helices in the x 1 5 g 2 Conformation , 2000 .
[71] L. Mirny,et al. Universally conserved positions in protein folds: reading evolutionary signals about stability, folding kinetics and function. , 1999, Journal of molecular biology.
[72] G J Barton,et al. Structural features can be unconserved in proteins with similar folds. An analysis of side-chain to side-chain contacts secondary structure and accessibility. , 1994, Journal of molecular biology.
[73] D. Larhammar,et al. Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT1B receptor , 1999 .
[74] Elaine C. Meng,et al. An Activation Switch in the Ligand Binding Pocket of the C5a Receptor* , 2001, The Journal of Biological Chemistry.
[75] M Krook,et al. Short-chain dehydrogenases/reductases (SDR). , 1995, Biochemistry.
[76] A. Karlin,et al. Substituted-cysteine accessibility method. , 1998, Methods in enzymology.
[77] T. Sakmar,et al. Functional Interaction of Transmembrane Helices 3 and 6 in Rhodopsin , 1996, The Journal of Biological Chemistry.
[78] H. Akil,et al. Site-directed mutagenesis of the human dopamine D2 receptor. , 1992, European journal of pharmacology.
[79] H Weinstein,et al. The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. , 2000, Biochemistry.
[80] D. Oprian,et al. STATE-DEPENDENT DISULFIDE CROSS-LINKING IN RHODOPSIN , 1999 .
[81] D. Pappin,et al. The structure of mammalian rod opsins , 1984, Vision Research.
[82] S. White,et al. Membrane protein folding and stability: physical principles. , 1999, Annual review of biophysics and biomolecular structure.
[83] C. Reynolds,et al. A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors. , 1997, Journal of medicinal chemistry.
[84] J. Ballesteros,et al. Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains. , 1992, Biophysical journal.
[85] C. Strader,et al. Structure-function analysis of the beta-adrenergic receptor. , 1988, Cold Spring Harbor symposia on quantitative biology.
[86] J. Javitch,et al. A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[87] H. Nelson,et al. Role of an alpha-helical bulge in the yeast heat shock transcription factor. , 2000, Journal of molecular biology.
[88] Leonardo Pardo,et al. Serine and Threonine Residues Bend α-Helices in the χ1 = g− Conformation , 2000 .
[89] J. Ballesteros,et al. The Forgotten Serine , 2000, The Journal of Biological Chemistry.
[90] T. Schwartz,et al. Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[91] E. Hulme,et al. A Network of Conserved Intramolecular Contacts Defines the Off-state of the Transmembrane Switch Mechanism in a Seven-transmembrane Receptor* , 2000, The Journal of Biological Chemistry.
[92] C. Strader,et al. Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. , 1988, The Journal of biological chemistry.
[93] J. Wess,et al. Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A2a Adenosine Receptor (*) , 1995, The Journal of Biological Chemistry.
[94] J. Wess,et al. Site‐directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. , 1991, The EMBO journal.
[95] J. Ballesteros,et al. The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. , 2000, Biochemistry.
[96] D. Donnelly,et al. The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor. , 1996, The Journal of Biological Chemistry.
[97] T. Sakmar,et al. Rhodopsin: structural basis of molecular physiology. , 2001, Physiological reviews.
[98] T. Schwartz,et al. Metal‐Ion Sites as Structural and Functional Probes of Helix–Helix Interactions in 7TM Receptors , 1997, Annals of the New York Academy of Sciences.
[99] C. Strader,et al. Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.
[100] B. Kobilka,et al. A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists. , 1991, The Journal of biological chemistry.
[101] S. Moro,et al. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. , 1998, Journal of medicinal chemistry.
[102] B. Kobilka,et al. Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity. , 1993, Molecular pharmacology.
[103] K. Jacobson,et al. A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor. , 1997, Molecular pharmacology.
[104] D. Oprian,et al. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness , 1994, Nature.
[105] J. Wess,et al. Mutational Analysis of the Relative Orientation of Transmembrane Helices I and VII in G Protein-coupled Receptors (*) , 1995, The Journal of Biological Chemistry.
[106] J. Ballesteros,et al. Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. , 1999, Molecular pharmacology.
[107] K Konvicka,et al. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. , 1994, Molecular pharmacology.
[108] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.
[109] B Honig,et al. An integrated approach to the analysis and modeling of protein sequences and structures. II. On the relationship between sequence and structural similarity for proteins that are not obviously related in sequence. , 2000, Journal of molecular biology.
[110] R. Schwyzer. 100 Years lock‐and‐key concept: Are peptide keys shaped and guided to their receptors by the target cell membrane? , 1995, Biopolymers.
[111] J. Javitch,et al. Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice. , 1995, Biochemistry.
[112] B. Lee,et al. The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.
[113] T. Sakmar,et al. Spectroscopic evidence for interaction between transmembrane helices 3 and 5 in rhodopsin. , 1998, Biochemistry.
[114] N. J. Gibson,et al. Lipid headgroup and acyl chain composition modulate the MI-MII equilibrium of rhodopsin in recombinant membranes. , 1993, Biochemistry.
[115] Jonathan A Javitch,et al. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method , 1995, Neuron.
[116] J. Demartino,et al. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. , 1994, The Journal of biological chemistry.
[117] M. Gerstein,et al. Assessing annotation transfer for genomics: quantifying the relations between protein sequence, structure and function through traditional and probabilistic scores. , 2000, Journal of molecular biology.
[118] J. Shafer,et al. Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate. , 1986, Biochemistry.
[119] D. Faury,et al. Demonstration by transfection studies that mutations in the adrenocorticotropin receptor gene are one cause of the hereditary syndrome of glucocorticoid deficiency. , 1996, The Journal of clinical endocrinology and metabolism.
[120] T. Ikegami,et al. Conformation of a peptide ligand bound to its G-protein coupled receptor , 2001, Nature Structural Biology.
[121] H. Khorana,et al. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.
[122] J. T. Turner,et al. Site-directed Mutagenesis of P2U Purinoceptors , 1995, The Journal of Biological Chemistry.
[123] H. Khorana,et al. Structure and function in rhodopsin. Cysteines 65 and 316 are in proximity in a rhodopsin mutant as indicated by disulfide formation and interactions between attached spin labels. , 1996, Biochemistry.
[124] J. Wess,et al. Use of a Disulfide Cross-linking Strategy to Study Muscarinic Receptor Structure and Mechanisms of Activation* , 1999, The Journal of Biological Chemistry.
[125] H. Feirabend,et al. Preservation and staining of myelinated nerve fibers. , 1998, Methods.
[126] A. Karlin,et al. Acetylcholine receptor channel structure probed in cysteine-substitution mutants. , 1992, Science.
[127] W. Greenlee,et al. Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: susceptibility to receptor mutations. , 1997, Molecular pharmacology.
[128] S. Lazareno,et al. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. , 1995, Molecular pharmacology.
[129] C. Strader,et al. Identification of residues required for ligand binding to the beta-adrenergic receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[130] L. F. Kolakowski,et al. The Role of the Cholecystokinin-B/Gastrin Receptor Transmembrane Domains in Determining Affinity for Subtype-selective Ligands(*) , 1995, The Journal of Biological Chemistry.
[131] A. Tucker,et al. A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition. , 1994, The Journal of biological chemistry.
[132] A. IJzerman,et al. Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[133] J. Klein-Seetharaman,et al. Structural features and light-dependent changes in the sequence 59-75 connecting helices I and II in rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.
[134] C. Fraser,et al. Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. , 1992, The Journal of biological chemistry.
[135] A. Shrake,et al. Environment and exposure to solvent of protein atoms. Lysozyme and insulin. , 1973, Journal of molecular biology.
[136] Takao Shimizu,et al. Alanine Exchanges of Polar Amino Acids in the Transmembrane Domains of a Platelet-activating Factor Receptor Generate Both Constitutively Active and Inactive Mutants* , 1997, The Journal of Biological Chemistry.
[137] M. Maze,et al. Arrangement of Transmembrane Domains in Adrenergic Receptors , 1996, The Journal of Biological Chemistry.
[138] B. O'dowd,et al. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors , 1992, Nature.